← FDA Drug Approvals (Drugs@FDA)

ANDA212606

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA MEDICARE · Approved 2020-01-30

Drug application

FDA Application #

ANDA212606

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

SHILPA MEDICARE

First approval

2020-01-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown